Pica as an adaptive response: Kaolin consumption helps rats recover from chemotherapy-induced illness

Physiology and Behavior

Volumn 97, Issue 1, 2009, Pages 87-90

  De Jonghe, Bart C ^a   Lawler, Maureen P ^a   Horn, Charles C ^a   Tordoff, Michael G ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

Author keywords

Cisplatin; Clay; Emesis; Nausea; Pica; Vagus

Indexed keywords

CISPLATIN; KAOLIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; PICA; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; CISPLATIN; DRINKING; DRUG INTERACTIONS; EATING; KAOLIN; MALE; PICA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 62749153239     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2009.02.009     Document Type: Article

References (36)

1. Engel C. Wild health: how animals keep themselves well and what we can learn from them (2002), Houghton Mifflin Company, Boston
2. Root-Bernstein R., and Root-Bernstein M. Honey, mud, maggots and other medical marvels (1997), Houghton Mifflin Company, Boston
3. Parry-Jones B., and Parry-Jones W.L. Pica: symptom or eating disorder? A historical assessment. Br J Psychiatry 160 (1992) 341-354
4. Rose E.A., Porcerelli J.H., and Neale A.V. Pica: common but commonly missed. J Am Board Fam Pract 13 (2000) 353-358
5. Thompson C. Terra sigillata, a famous medicament of ancient times. 17th Intern Med Congr, Mistory Med (1913) Sect 23:433
6. Johns T., and Duquette M. Detoxification and mineral supplementation as functions of geophagy. Am J Clin Nutr 53 (1991) 448-456
7. Singhi S., Ravishanker R., Singhi P., and Nath R. Low plasma zinc and iron in pica. Indian J Pediatr 70 (2003) 139-143
8. Phillips T.D., Sarr A.B., and Grant P.G. Selective chemisorption and detoxification of aflatoxins by phyllosilicate clay. Nat Toxins 3 (1995) 204-213
9. Phillips T.D. Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicol Sci 52 (1999) 118-126
10. Sarr A.B., Mayura K., Kubena L.F., Harvey R.B., and Phillips T.D. Effects of phyllosilicate clay on the metabolic profile of aflatoxin B1 in Fischer-344 rats. Toxicol Lett 75 (1995) 145-151
11. Reid R.M. Cultural and medical perspectives on geophagia. Med Anthropol 13 (1992) 337-351
12. Stokes T. The earth-eaters. Nature 444 (2006) 543-544
13. Mitchell D., Laycock J.D., and Stephens W.F. Motion sickness-induced pica in the rat. Am J Clin Nutr 30 (1977) 147-150
14. Patterson E.C., and Staszak D.J. Effects of geophagia (kaolin ingestion) on the maternal blood and embryonic development in the pregnant rat. J Nutr 107 (1977) 2020-2025
15. Cepeda V., Fuertes M.A., Castilla J., Alonso C., Quevedo C., and Perez J.M. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem 7 (2007) 3-18
16. Andrews P.L., and Horn C.C. Signals for nausea and emesis: implications for models of upper gastrointestinal diseases. Auton Neurosci 125 (2006) 100-115
17. Andrews P.L.R., and Rudd J.A. The role of tachykinins and the tachykinin NK1 receptor in nausea and emesis. In: Holzer P. (Ed). Handbook of experimental pharmacology (2004), Springer Verlag, New York 359-441
18. Rudd J.A., and Andrews P.L.R. Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In: Hesketh P.J., and Sudbury M.A. (Eds). Management of nausea and vomiting in caner and cancer treatment (2005), Jones and Bartlett 15-65
19. Malik N.M., Liu Y.L., Cole N., Sanger G.J., and Andrews P.L. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol. 555 2-3 (2007) 164-173
20. Takeda N., Hasegawa S., Morita M., and Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav 45 (1993) 817-821
21. Vera G., Chiarlone A., Martin M.I., and Abalo R. Altered feeding behaviour induced by long-term cisplatin in rats. Auton Neurosci 126-127 (2006) 81-92
22. De Jonghe B.C., and Horn C.C. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. Am J Physiol Regul Integr Comp Physiol 294 (2008) R756-R765
23. Saeki M., Sakai M., Saito R., Kubota H., Ariumi H., Takano Y., et al. Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats. Jpn J Pharmacol 86 (2001) 359-362
24. Malik N.M., Liu Y.L., Cole N., Sanger G.J., and Andrews P.L. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur J Pharmacol 555 (2007) 164-173
25. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B 57 (1995) 289-pBenjamini Y and Hochberg Y300
26. Litterst C.L., LeRoy A.F., and Guarino A.M. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals. Cancer Treat Rep 63 (1979) 1485-1492
27. Bearcroft C.P., Domizio P., Mourad F.H., Andre E.A., and Farthing M.J. Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine. Gut 44 (1999) 174-179
28. Malik N.M., Moore G.B., Kaur R., Liu Y.L., Wood S.L., Morrow R.W., et al. Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia. Regul Pept 148 1-3 (2008) 33-38
29. Webster L.K., Ellis A.G., Apicella C., and Deacon G.B. Atypical pharmacokinetics and excretion of new platinum analogues in rodents. Cancer Chemother Pharmacol 49 (2002) 87-92
30. Litterst C.L., Gram T.E., Dedrick R.L., LeRoy A.F., and Guarino A.M. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs. Cancer Res 36 (1976) 2340-2344
31. Beck I.T., Jenkins N., Thurber L., and Ambrus J.L. Methods for the study of antidiarrheal agents. Study of commonly used protective and adsorbent agents. J Med 8 (1977) 135-158
32. Blachley J.D., and Hill J.B. Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95 (1981) 628-632
33. Gordon J.A., Peterson L.N., and Anderson R.J. Water metabolism after cisplatin in the rat. Am J Physiol 243 (1982) F36-F43
34. Mele P.C., McDonough J.R., McLean D.B., and O'Halloran K.P. Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F. Eur J Pharmacol 218 (1992) 229-236
35. Jacobsen P.B., Bovbjerg D.H., Schwartz M.D., Andrykowski M.A., Futterman A.D., Gilewski T., et al. Formation of food aversions in cancer patients receiving repeated infusions of chemotherapy. Behav Res Ther 31 (1993) 739-748
36. Schwartz M.D., Jacobsen P.B., and Bovbjerg D.H. Role of nausea in the development of aversions to a beverage paired with chemotherapy treatment in cancer patients. Physiol Behav 59 (1996) 659-663